PAPILLARY RENAL CELL CARCINOMA (PRCC)
Clinical trials for PAPILLARY RENAL CELL CARCINOMA (PRCC) explained in plain language.
Never miss a new study
Get alerted when new PAPILLARY RENAL CELL CARCINOMA (PRCC) trials appear
Sign up with your email to follow new studies for PAPILLARY RENAL CELL CARCINOMA (PRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to fight tough kidney cancers
Disease control Recruiting nowThis study tests two drugs—palbociclib (a daily pill) and sasanlimab (a monthly injection)—in people with advanced kidney cancer (clear cell or papillary type). The goal is to see if the combination can shrink tumors or stop them from growing. About 100 adults will take part for …
Matched conditions: PAPILLARY RENAL CELL CARCINOMA (PRCC)
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug SIM0505 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called SIM0505 in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and check for any early signs that the drug shrinks tumors. About 414 participants will re…
Matched conditions: PAPILLARY RENAL CELL CARCINOMA (PRCC)
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC